Andreas Geier

机构：Universitätsklinikum Würzburg · ORCID：0000-0002-9626-5083

发表论文 528 篇 · 总被引 19656 次 · h-index 61

代表论文

• Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation (2025 · European Journal of Clinical Investigation · 被引 41)
• Metabolic Dysfunction–Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus Panel (2025 · Liver International · 被引 12)
• Limitations of Guideline‐Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug Treatments (2025 · Liver International · 被引 10)
• Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-Associated Steatohepatitis (2025 · Clinical Gastroenterology and Hepatology · 被引 6)
• Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity (2025 · JHEP Reports · 被引 6)
• Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistance (2025 · Cellular Oncology · 被引 4)